Cellectis Provides Business Update and Reports Financial Results for First Quarter 2023

May 4, 2023

https://www.globenewswire.com/news-release/2023/05/04/2662135/0/en/Cellectis-Provides-Business-Update-and-Reports-Financial-Results-for-First-Quarter-2023.html

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today provided a business update and announced its results for the three-month period ending March 31, 2023.

Read more at globenewswire.com

Related news for (CLLS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.